Glutamine supplementation in colorectal cancer [2]

Colorectal Disease

Volumn 9, Issue 9, 2007, Pages 852-

  O'Dwyer, Siobhan T ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUTAMINE;

BONE MARROW TRANSPLANTATION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM CANCER; DISEASE FREE SURVIVAL; ELECTIVE SURGERY; HUMAN; LETTER; MICROMETASTASIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; UPREGULATION;

COLORECTAL NEOPLASMS; FOOD, FORMULATED; GLUTAMINE; HUMANS; POSTOPERATIVE COMPLICATIONS; TIME FACTORS; TREATMENT OUTCOME;

EID: 35348817367     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2007.01391.x     Document Type: Letter

References (5)

1. Oguz M, Kerem M, Bedirli A, Mentes BB, Sakrak O, Salman B, Bostanci H. l-Alanin-l-Glutamine supplementation improves the outcome after colorectal surgery for cancer. Colorectal Dis 2007; 9: 521-6.
2. Avenell A. Glutamine in critical care: Current evidence from systematic reviews. Proc Nutr Soc 2006; 65: 236-41.
3. Alpers D. Glutamine: Do the data support the cause for glutamine supplementation in humans? Gastroenterology 2006; 130 (Suppl. 1): S106-16.
4. O'Dwyer ST, Smith RJ, Rombeau JL, Wilmore DW. Tissue specific regulation of glutamine metabolism in muscle and intestine. Am J Clin Nutr 1991; 2: 241-7.
5. Sykorova A, Horacek J, Zak P, Kmonicek M, Bukac J, Maly J. A randomized, double blind comparative study of prophylactic parenteral nutritional support with or without glutamine in autologous stem cell transplantation for hematological malignancies -three years follow-up. Neoplasma 2005; 52: 476-82.